Rallybio Corporation RLYB
Set alert
As of Nov 3, 10:05 AM ET
- YTD
- +191.35%
- 1 year
- +199.53%
- Open
- 15.76
- Prev close
- 15.76
- Mkt cap
- 86.12M
- Vol
- 4.06K
- Avg vol
- 16.90K
- EPS
- 4.61
- P/E
- 3.47
- Div yield
- 0.00%
More statistics
- Low
- 15.72
- High
- 16.11
- Forward P/E
- -0.72
- Beta
- -1.67
- Short ratio
- 5.26
- Inst. own
- 76.27%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 8, 2024
- 50-d avg
- 1.05
- 200-d avg
- 1.35
- 1y target
- 8.25
5D chart
Signals (85)
| Name | Time | Ago |
|---|---|---|
| SMA: Bearish | Nov 2, 3:55 PM | 18 hours ago |
| MACD: Sell Signal | Nov 2, 3:55 PM | 18 hours ago |
| SMA: Bullish | Nov 2, 3:40 PM | 18 hours ago |
| SMA: Bearish | Nov 2, 3:35 PM | 18 hours ago |
| MACD: Buy Signal | Nov 2, 3:25 PM | 19 hours ago |
| SMA: Bullish | Nov 2, 3:05 PM | 19 hours ago |
| SMA: Bearish | Nov 2, 2:00 PM | 20 hours ago |
| SMA: Bearish | Nov 2, 2:00 PM | 20 hours ago |
| SMA: Bullish | Nov 2, 1:55 PM | 20 hours ago |
| SMA: Bullish | Nov 2, 1:55 PM | 20 hours ago |
| SMA: Bearish | Nov 2, 1:50 PM | 20 hours ago |
| SMA: Bearish | Nov 2, 1:50 PM | 20 hours ago |
| SMA: Bullish | Nov 2, 1:45 PM | 20 hours ago |
| SMA: Bullish | Nov 2, 1:45 PM | 20 hours ago |
| SMA: Bearish | Nov 2, 1:40 PM | 20 hours ago |
| SMA: Bearish | Nov 2, 1:40 PM | 20 hours ago |
| SMA: Bullish | Nov 2, 12:55 PM | 21 hours ago |
| SMA: Bullish | Nov 2, 12:55 PM | 21 hours ago |
| SMA: Bearish | Nov 2, 12:50 PM | 21 hours ago |
| SMA: Bearish | Nov 2, 12:50 PM | 21 hours ago |
Newest 20 of 85.
News
-
1 week ago benzinga.com
Rallybio Q3 EPS $(0.48) Misses $(0.21) Estimate
Rallybio (NASDAQ:RLYB) reported quarterly losses of $(0.48) per share which missed the analyst consensus estimate of $(0.21) by 128.57 percent. This is a 57.14 percent increase over losses of $(1.12)…
-
1 week ago benzinga.com
Rallybio Declares $82.7M Special Cash Distribution To Stockholders And Pre-Funded Warrant Holders, Estimated At $13.56/Share, In Connection With Avenzo Therapeutics Merger
As previously disclosed, on May 31, 2026, the Rallybio Corporation, a Delaware corporation (the "Company"), entered into an Agreement and Plan of Merger and Reorganization (the "Merger Agreement")…
-
5 months ago benzinga.com
Rallybio To Acquire Avenzo Therapeutics; Avenzo Entered Into $215M Private Placement Financing
About the Proposed Transaction Under the terms of the merger agreement, Rallybio will acquire Avenzo pursuant to the Merger. At the closing of the Merger, Avenzo stockholders will receive newly…
6 months ago benzinga.com
12 Health Care Stocks Moving In Monday's Intraday Session
12 Health Care Stocks Moving In Monday's Intraday Session
6 months ago benzinga.com
12 Health Care Stocks Moving In Monday's Pre-Market Session
12 Health Care Stocks Moving In Monday's Pre-Market Session
6 months ago benzinga.com
Why eBay Shares Are Trading Higher By 8%; Here Are 20 Stocks Moving Premarket
eBay (NASDAQ: EBAY) rose sharply after GameStop (NYSE: GME) proposed to acquire it for $125/share, valuing GME at $55.5B. eBay shares jumped 8.1% to $112.50 in pre-market trading.
6 months ago benzinga.com
12 Health Care Stocks Moving In Monday's Pre-Market Session
12 Health Care Stocks Moving In Monday's Pre-Market Session
8 months ago benzinga.com
12 Health Care Stocks Moving In Monday's After-Market Session
12 Health Care Stocks Moving In Monday's After-Market Session
-
8 months ago benzinga.com
12 Health Care Stocks Moving In Monday's Intraday Session
12 Health Care Stocks Moving In Monday's Intraday Session
8 months ago benzinga.com
Tiny Biotech Rallybio Stock Surges As $500 Million-Backed Merger Fuels Investor Optimism
Rallybio stock jumps after announcing a $505 million merger with Candid Therapeutics, boosting cash to $700 million.
-
8 months ago benzinga.com
Rallybio To Acquire Candid Therapeutics Under All-Stock Merger Agreement
Following closing, pre-Transaction Rallybio equityholders are expected to own approximately 3.65% of the combined company, and pre-Transaction Candid equityholders (inclusive of investors…
8 months ago benzinga.com
Rallybio Shares Successful Early-Stage Results for Rare Disease Drug; New Trial Set for Late 2026
Rallybio reports strong Phase 1 results for RLYB116, showing full immune pathway control with good safety and Phase 2 plans ahead.
-
8 months ago benzinga.com
Rallybio Reports Results From Phase 1 Confirmatory PK/PD Clinical Trial Evaluating RLYB116 In Development For Patients With Complement-Mediated Diseases With Initial Focus On Immune PTR And Refractory APS
– Data Support the Study of RLYB116 as a Potential Best-In-Class Therapeutic for Multiple Complement Mediated Diseases –– Initiation of RLYB116 Phase 2 Clinical Trial in Immune Platelet Transfusion…
-
9 months ago benzinga.com
Rallybio Announces 1-For-8 Reverse Stock Split
Rallybio Corporation (NASDAQ:RLYB) will effect a one-for-eight reverse stock split of its issued and outstanding common stock. Stockholders of Rallybio approved an amendment to Rallybio's Amended and…
-
10 months ago benzinga.com
12 Health Care Stocks Moving In Wednesday's After-Market Session
12 Health Care Stocks Moving In Wednesday's After-Market Session
-
12 months ago benzinga.com
UPDATE: Rallybio Q3 Adj. EPS $(0.14) Beats $(0.21) Estimate, Sales $212.000K Beat $66.667K Estimate
Rallybio (NASDAQ:RLYB) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate of $(0.21) by 34.58 percent. This is a 46.15 percent increase over losses of $(0.26)…
-
12 months ago benzinga.com
Rallybio Q3 EPS $0.36 Beats $(0.21) Estimate, Sales $212.000K Beat $66.667K Estimate
Rallybio (NASDAQ:RLYB) reported quarterly earnings of $0.36 per share which beat the analyst consensus estimate of $(0.21) by 269.01 percent. This is a 238.46 percent increase over losses of $(0.26)…
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Thursday's After-Market Session
12 Health Care Stocks Moving In Thursday's After-Market Session
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Thursday's After-Market Session
12 Health Care Stocks Moving In Thursday's After-Market Session
-
1 year ago benzinga.com
Rallybio Completes Dosing For First Cohort In Phase 1 Confirmatory PK/PD Study Of RLYB116 Its Once-Weekly, Small-Volume, Subcutaneous C5 Inhibitor Being Developed To Treat Rare Diseases
Rallybio Corporation (NASDAQ: RLYB), a clinical-stage biotechnology company translating scientific advances into transformative therapies for patients with devastating rare diseases, today announced…
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session
12 Health Care Stocks Moving In Tuesday's After-Market Session
-
1 year ago benzinga.com
Rallybio Q2 EPS $(0.22) Beats $(0.24) Estimate, Sales $212.000K Down From $299.000K YoY
Rallybio (NASDAQ:RLYB) reported quarterly losses of $(0.22) per share which beat the analyst consensus estimate of $(0.24) by 10.2 percent. This is a 40.54 percent increase over losses of $(0.37) per…
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Monday's After-Market Session
12 Health Care Stocks Moving In Monday's After-Market Session
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session
12 Health Care Stocks Moving In Tuesday's Intraday Session
1 year ago benzinga.com
Why Is Microcap Rallybio Stock Trading Higher On Tuesday?
Rallybio sells its stake in preclinical HPP drug REV102 to Recursion in a deal worth up to $25 million, including equity and milestone payments.
-
1 year ago benzinga.com
Recursion Acquires Rallybio's Full Interest In Joint ENPP1 Inhibitor Program And Associated Backup Molecule For Treatment Of Hypophosphatasia; Rallybio To Receive $7.5M Upfront, With Potential For $17.5M More In Preclinical And Clinical Milestones
Recursion (NASDAQ:RXRX) a leading clinical stage TechBio company decoding biology to radically improve lives today announced the acquisition of Rallybio's (NASDAQ:RLYB) full interest in their joint…
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Monday's After-Market Session
12 Health Care Stocks Moving In Monday's After-Market Session
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Friday's After-Market Session
12 Health Care Stocks Moving In Friday's After-Market Session
-
1 year ago benzinga.com
Rallybio Initiates Dosing In Phase 1 Confirmatory PK/PD Study Evaluating RLYB116, Subcutaneously Injected C5 Inhibitor
– Potential to Address a Broad Range of Complement-Mediated Diseases with Initial Focus on Immune Platelet Transfusion Refractoriness and Refractory Antiphospholipid Syndrome –– Data Readouts…
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session
12 Health Care Stocks Moving In Wednesday's Intraday Session
-
1 year ago benzinga.com
Rallybio Q1 EPS $(0.21) Beats $(0.26) Estimate, Sales $212.00K
Rallybio (NASDAQ:RLYB) reported quarterly losses of $(0.21) per share which beat the analyst consensus estimate of $(0.26) by 19.23 percent. This is a 55.32 percent increase over losses of $(0.47)…
1 year ago benzinga.com
This General Motors Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
This General Motors Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
1 year ago benzinga.com
This PTC Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
This PTC Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session
12 Health Care Stocks Moving In Tuesday's Intraday Session
1 year ago benzinga.com
Rallybio Stock Plunges After Program For Pediatric Bleeding Disorder Disappoints
Rallybio ends RLYB212 trial for FNAIT; shifts focus to RLYB116 and preclinical assets with 2025 trial milestones and $6 billion market potential.
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session
12 Health Care Stocks Moving In Tuesday's After-Market Session
-
1 year ago benzinga.com
HC Wainwright & Co. Reiterates Buy on Rallybio, Maintains $5 Price Target
HC Wainwright & Co. analyst Mitchell Kapoor reiterates Rallybio (NASDAQ:RLYB) with a Buy and maintains $5 price target.
-
2 years ago benzinga.com
Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of Fastenal Company (NASDAQ: FAST) fell sharply during Thursday’s session following worse-than-expected first-quarter financial results.
-
2 years ago benzinga.com
Enliven Therapeutics, Alpine Immune Sciences, Janux Therapeutics And Other Big Stocks Moving Higher On Thursday
U.S. stocks were mixed, with the Dow Jones index falling over 50 points on Thursday. Shares of Enliven Therapeutics, Inc. (NASDAQ: ELVN) rose sharply during Thursday’s session.
-
2 years ago benzinga.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session
12 Health Care Stocks Moving In Thursday's Pre-Market Session
-
3 years ago benzinga.com
Stocks That Hit 52-Week Lows On Monday
On Monday, 369 companies set new 52-week lows.
-
3 years ago benzinga.com
Why Couchbase Shares Are Trading Lower By Around 19%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Mobiquity Technologies, Inc. (NASDAQ: MOBQ) shares gained 124% to $0.3325. Mobiquity Technologies launched ElecAlytics, an AI-Powered analytics suite added to its ElecTech platform for…
-
3 years ago benzinga.com
Stocks That Hit 52-Week Lows On Monday
On Monday, 198 companies hit new 52-week lows.
-
3 years ago benzinga.com
Stocks That Hit 52-Week Lows On Monday
Monday saw 196 companies set new 52-week lows.
-
3 years ago benzinga.com
Stocks That Hit 52-Week Lows On Wednesday
Wednesday saw 219 companies set new 52-week lows.
-
3 years ago benzinga.com
Why Tattooed Chef Shares Dipped Around 15%; Here Are 95 Biggest Movers From Friday
Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares surged 56.6% to settle at $19.10 on Friday.
-
3 years ago benzinga.com
Why Compass Shares Are Trading Higher By Over 56%? Here Are 63 Stocks Moving In Friday's Mid-Day Session
Gainers Snail, Inc. (NASDAQ: SNAL) shares jumped 74.9% to $3.9350 after the company announced a $5 million share repurchase program.
-
3 years ago benzinga.com
Stocks That Hit 52-Week Lows On Friday
On Friday, 63 stocks hit new 52-week lows.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Tuesday
On Tuesday, 951 companies hit new 52-week lows.